Association of Sleep Duration with Cardio-metabolic Risk Leading to Development of Atherosclerotic Cardiovascular Disease

Association of Sleep Duration with Cardio-metabolic Risk in Japanese : A Crosse-sectional Study - Adequate sleep duration and cardio-metabolic risk

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037643

Enrollment

10000

Registered

2019-08-09

Start date

2019-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerotic cardiovascular disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Apparently healthy males who had undergone health check examinations at the Health Planning Center of Nihon University Hospital

Exclusion criteria

Exclusion criteria: The exclusion criteria included refusal to provide consent for participation in the study, current treatment of insulin therapy, positive history of atherosclerotic cardiovascular disease (ASCVD), absence of measurement of the serum lipid, fasting blood glucose, immunoreactive insulin, hemoglobin A1c (HbA1c), waist circumference (WC) and absence of a record of the average sleep duration per week.

Design outcomes

Primary

Measure	Time frame
The primary efficacy parameter was the relationship between sleep duration and cardio-metabolic risk: WC, HbA1c, Homeostatic model assessment insulin resistance (HOMA-IR), and serum non-high-density lipoprotein cholesterol (non-HDL-C) level.	—

Countries

Japan

Contacts

Public ContactShigemasa Tani

Nihon University Hospital Health Planning Center

tani.shigemasa@nihon-u.ac.jp0332931711

Outcome results